FR2264540B1 - - Google Patents

Info

Publication number
FR2264540B1
FR2264540B1 FR7410678A FR7410678A FR2264540B1 FR 2264540 B1 FR2264540 B1 FR 2264540B1 FR 7410678 A FR7410678 A FR 7410678A FR 7410678 A FR7410678 A FR 7410678A FR 2264540 B1 FR2264540 B1 FR 2264540B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7410678A
Other versions
FR2264540A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2264540A1 publication Critical patent/FR2264540A1/fr
Application granted granted Critical
Publication of FR2264540B1 publication Critical patent/FR2264540B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7410678A 1972-09-28 1974-03-20 Expired FR2264540B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2247538A DE2247538C2 (de) 1972-09-28 1972-09-28 Antitussivum

Publications (2)

Publication Number Publication Date
FR2264540A1 FR2264540A1 (fr) 1975-10-17
FR2264540B1 true FR2264540B1 (fr) 1977-11-04

Family

ID=5857605

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7410678A Expired FR2264540B1 (fr) 1972-09-28 1974-03-20

Country Status (9)

Country Link
US (1) US3917836A (fr)
AU (1) AU6722474A (fr)
BE (1) BE813175A (fr)
CH (1) CH590850A5 (fr)
DE (1) DE2247538C2 (fr)
FR (1) FR2264540B1 (fr)
GB (1) GB1409993A (fr)
LU (1) LU69722A1 (fr)
NL (1) NL157207B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2415740C2 (de) * 1974-04-01 1983-12-01 Servomed Arznei GmbH & Co Pharma KG, 8000 München Verwendung von Orotsäure bei der analgetischen Behandlung mit Dextropropoxyphen, Natriumsalicylat oder Metamizol
JP4347041B2 (ja) * 2001-06-11 2009-10-21 協和発酵バイオ株式会社 消炎、鎮咳組成物
US8034823B2 (en) * 2005-02-22 2011-10-11 Savvipharm Inc Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
US7470672B2 (en) * 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives

Also Published As

Publication number Publication date
NL7403931A (nl) 1975-09-24
US3917836A (en) 1975-11-04
DE2247538C2 (de) 1975-03-06
CH590850A5 (fr) 1977-08-31
NL157207B (nl) 1978-07-17
FR2264540A1 (fr) 1975-10-17
LU69722A1 (fr) 1974-07-17
DE2247538B1 (de) 1974-07-18
DE2247538A1 (de) 1974-05-02
BE813175A (fr) 1974-10-02
AU6722474A (en) 1975-10-02
GB1409993A (en) 1975-10-15

Similar Documents

Publication Publication Date Title
DK141685C (fr)
JPS5122345B2 (fr)
FR2192389A1 (fr)
FR2176132A1 (fr)
FR2264540B1 (fr)
FR2180378A5 (fr)
JPS511250B2 (fr)
JPS4928066U (fr)
JPS4988134A (fr)
JPS5352911Y2 (fr)
JPS5129070Y2 (fr)
JPS5245480B2 (fr)
JPS51359B2 (fr)
JPS4897906U (fr)
RO61848A2 (fr)
FR2167643A1 (fr)
RO59874A2 (fr)
FR2189788A1 (fr)
JPS4994624U (fr)
JPS4879872A (fr)
CH571798A5 (fr)
CH568828A5 (fr)
CH561435A5 (fr)
BG18120A1 (fr)
BG18147A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse